clinical trial · NCT06220123
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Beijing Suncadia Pharmaceuticals Co., Ltd·phase2·completed·n = 225
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer SurgerySHR-2004Enoxaparin Sodium Injection; Rivaroxaban Tablets
brief summary
This study is designed to evaluate the efficacy and safety of SHR-2004 injection in preventing postoperative venous thromboembolism in patients undergoing ovarian cancer surgery.
started
Feb 16, 2024
primary completion
Dec 31, 2024
completion
Dec 31, 2024
last updated
Jul 22, 2025
official title
A Multicenter, Randomized, Open-label, Active-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol